Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Polyrizon Submites Patent Application For Its Platform Technologies

Tel Aviv, Israel, Sept. 12, 2022 (GLOBE NEWSWIRE) — Medigus Ltd. (NASDAQ:MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle ("EV") and
byBill Haddad
September 12, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Tel Aviv, Israel, Sept. 12, 2022 (GLOBE NEWSWIRE) — Medigus Ltd. (NASDAQ:MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, announced today that Polyrizon Ltd. (“Polyrizon”), a privately held company in which Medigus owns 37.03%, has submitted a PCT (Patent Cooperation Treaty) application, following a submission to the United States Patent and Trademark Office for its innovative technology.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Biomea Fusion Presents Long-Term Follow-Up Data Showing Improved Glycemic Control After 22 Weeks Off Treatment In Ongoing Phase II Study Of BMF-219 In Adults With Type 2 Diabetes In Poster Presentation At WCIRDC

By Benzinga Newsdesk
December 8, 10:06 AM
BMF-219 is an investigational novel covalent menin inhibitor developed to regenerate insulin-producing beta cells with the aim to cure diabetesAt Week 26, 22 weeks after the last dose of BMF-219, participants in the 100

BMEA